يعرض 1 - 10 نتائج من 32 نتيجة بحث عن '"Lara, Olivia D."', وقت الاستعلام: 1.63s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية
  8. 8
    دورية أكاديمية

    المساهمون: Cancer Prevention and Research Institute of Texas, American Cancer Society, National Science Foundation, U.S. Department of Health & Human Services | NIH | Center for Scientific Review, U.S. Department of Health & Human Services | NIH | National Cancer Institute, Frank McGraw Memorial Chair in Cancer Research

    المصدر: Scientific Reports ; volume 9, issue 1 ; ISSN 2045-2322

    مصطلحات موضوعية: Multidisciplinary

  9. 9
  10. 10
    دورية أكاديمية

    وصف الملف: application/pdf

    العلاقة: Lara, Olivia D.; Wang, Ying; Asare, Amma; Xu, Tao; Chiu, Hua‐sheng; Liu, Yuexin; Hu, Wei; Sumazin, Pavel; Uppal, Shitanshu; Zhang, Lin; Rauh‐hain, J. Alejandro; Sood, Anil K. (2020). "Panâ cancer clinical and molecular analysis of racial disparities." Cancer (4): 800-807.; https://hdl.handle.net/2027.42/153667Test; Cancer; Egawa H, Jingushi K, Hirono T, et al. The miRâ 130 family promotes cell migration and invasion in bladder cancer through FAK and Akt phosphorylation by regulating PTEN. Sci Rep. 2016; 6: 20574.; Brewer LC, Redmond N, Slusser JP, et al. Stress and achievement of cardiovascular health metrics: the American Heart Association Life’s Simple 7 in blacks of the Jackson Heart Study. J Am Heart Assoc. 2018; 7: e008855.; Grossman RL, Heath AP, Ferretti V, et al. Toward a shared vision for cancer genomic data. N Engl J Med. 2016; 375: 1109 â 1112.; Pounds S, Morris SW. Estimating the occurrence of false positives and false negatives in microarray studies by approximating and partitioning the empirical distribution of pâ values. Bioinformatics. 2003; 19: 1236 â 1242.; Li J, Han L, Roebuck P, et al. TANRIC: an interactive open platform to explore the function of lncRNAs in cancer. Cancer Res. 2015; 75: 3728 â 3737.; Chiu Hâ S, Somvanshi S, Patel E, et al. Panâ cancer analysis of lncRNA regulation supports their targeting of cancer genes in each tumor context. Cell Rep. 2018; 23: 297 â 312.; Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledgeâ based approach for interpreting genomeâ wide expression profiles. Proc Natl Acad Sci U S A. 2005; 102: 15545 â 15550.; Geretto M, Pulliero A, Rosano C, Zhabayeva D, Bersimbaev R, Izzotti A. Resistance to cancer chemotherapeutic drugs is determined by pivotal microRNA regulators. Am J Cancer Res. 2017; 7: 1350 â 1371.; Jiang H, Yu WW, Wang LL, Peng Y. miRâ 130a acts as a potential diagnostic biomarker and promotes gastric cancer migration, invasion and proliferation by targeting RUNX3. Oncol Rep. 2015; 34: 1153 â 1161.; Zhang HD, Jiang LH, Sun DW, Li J, Ji ZL. The role of miRâ 130a in cancer. Breast Cancer. 2017; 24: 521 â 527.; Sueta A, Yamamoto Y, Tomiguchi M, Takeshita T, Yamamotoâ Ibusuki M, Iwase H. Differential expression of exosomal miRNAs between breast cancer patients with and without recurrence. Oncotarget. 2017; 8: 69934 â 69944.; Ma W, Ma CN, Zhou NN, Li XD, Zhang YJ. Upâ regulation of miRâ 328â 3p sensitizes nonâ small cell lung cancer to radiotherapy. Sci Rep. 2016; 6: 31651.; Feng Y, Bai F, You Y, et al. Dysregulated microRNA expression profiles in gastric cancer cells with high peritoneal metastatic potential. Exp Ther Med. 2018; 16: 4602 â 4608.; Shi Q, Zhou Z, Ye N, Chen Q, Zheng X, Fang M. MiRâ 181a inhibits nonâ small cell lung cancer cell proliferation by targeting CDK1. Cancer Biomark. 2017; 20: 539 â 546.; Meijer LL, Garajova I, Caparello C, et al. Plasma miRâ 181aâ 5p downregulation predicts response and improved survival after FOLFIRINOX in pancreatic ductal adenocarcinoma. Ann Surg. Published online December 9, 2018. doi:10.1097/SLA.0000000000003084; Pignot G, Cizeronâ Clairac G, Vacher S, et al. microRNA expression profile in a large series of bladder tumors: identification of a 3â miRNA signature associated with aggressiveness of muscleâ invasive bladder cancer. Int J Cancer. 2013; 132: 2479 â 2491.; Lin C, Li Z, Chen P, et al. Oncogene miRâ 154â 5p regulates cellular function and acts as a molecular marker with poor prognosis in renal cell carcinoma. Life Sci. 2018; 209: 481 â 489.; Aqeilan RI, Calin GA, Croce CM. miRâ 15a and miRâ 16â 1 in cancer: discovery, function and future perspectives. Cell Death Differ. 2010; 17: 215 â 220.; Zhu Y, Gu J, Li Y, et al. MiRâ 17â 5p enhances pancreatic cancer proliferation by altering cell cycle profiles via disruption of RBL2/E2F4â repressing complexes. Cancer Lett. 2018; 412: 59 â 68.; Duan J, Zhang H, Qu Y, et al. Oncoâ miRâ 130 promotes cell proliferation and migration by targeting TGFbetaR2 in gastric cancer. Oncotarget. 2016; 7: 44522 â 44533.; He DX, Ma X. Transient receptor potential channel C5 in cancer chemoresistance. Acta Pharmacol Sin. 2016; 37: 19 â 24.; Ma X, Chen Z, Hua D, et al. Essential role for TrpC5â containing extracellular vesicles in breast cancer with chemotherapeutic resistance. Proc Natl Acad Sci U S A. 2014; 111: 6389 â 6394.; Filipska M, Skrzypski M, Czetyrbok K, et al. MiRâ 192 and miRâ 662 enhance chemoresistance and invasiveness of squamous cell lung carcinoma. Lung Cancer. 2018; 118: 111 â 118.; Qian J, Ding F, Luo A, Liu Z, Cui Z. Overexpression of S100A14 in human serous ovarian carcinoma. Oncol Lett. 2016; 11: 1113 â 1119.; Loomis D, Guyton KZ, Grosse Y, et al. Carcinogenicity of drinking coffee, mate, and very hot beverages. Lancet Oncol. 2016; 17: 877 â 878.; Sturtz LA, Melley J, Mamula K, Shriver CD, Ellsworth RE. Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer. BMC Cancer. 2014; 14: 62.; Cote ML, Ruterbusch JJ, Olson SH, Lu K, Aliâ Fehmi R. The growing burden of endometrial cancer: a major racial disparity affecting black women. Cancer Epidemiol Biomarkers Prev. 2015; 24: 1407 â 1415.; Deshmukh SK, Srivastava SK, Tyagi N, et al. Emerging evidence for the role of differential tumor microenvironment in breast cancer racial disparity: a closer look at the surroundings. Carcinogenesis. 2017; 38: 757 â 765.; Deshmukh SK, Srivastava SK, Bhardwaj A, et al. Resistin and interleukinâ 6 exhibit raciallyâ disparate expression in breast cancer patients, display molecular association and promote growth and aggressiveness of tumor cells through STAT3 activation. Oncotarget. 2015; 6: 11231 â 11241.; Martin DN, Boersma BJ, Yi M, et al. Differences in the tumor microenvironment between Africanâ American and Europeanâ American breast cancer patients. PLoS One. 2009; 4: e4531.; Spratt DE, Chan T, Waldron L, et al. Racial/ethnic disparities in genomic sequencing. JAMA Oncol. 2016; 2: 1070 â 1074.; Frey MK, Moss HA, Musa F, et al. Preoperative experience for public hospital patients with gynecologic cancer: do structural barriers widen the gap? Cancer. 2016; 122: 859 â 867.; Hall JE, Moonesinghe R, Bouye K, Penmanâ Aguilar A. Racial/ethnic disparities in mortality: contributions and variations by rurality in the United States, 2012â 2015. Int J Environ Res Public Health. 2019; 16: 436.; Allard JE, Maxwell GL. Race disparities between black and white women in the incidence, treatment, and prognosis of endometrial cancer. Cancer Control. 2009; 16: 53 â 56.; Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB. Survival of blacks and whites after a cancer diagnosis. JAMA. 2002; 287: 2106 â 2113.; Howard J, Hankey BF, Greenberg RS, et al. A collaborative study of differences in the survival rates of black patients and white patients with cancer. Cancer. 1992; 69: 2349 â 2360.; DeSantis CE, Miller KD, Goding Sauer A, Jemal A, Siegel RL. Cancer statistics for African Americans, 2019. CA Cancer J Clin. 2019; 69: 211 â 233.; Newman LA. Disparities in breast cancer and African ancestry: a global perspective. Breast J. 2015; 21: 133 â 139.; Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002; 94: 334 â 357.; Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004; 54: 78 â 93.; Williams DR, Mohammed SA, Shields AE. Understanding and effectively addressing breast cancer in African American women: unpacking the social context. Cancer. 2016; 122: 2138 â 2149.; Newman LA, Stark A, Chitale D, et al. Association between benign breast disease in African American and white American women and subsequent tripleâ negative breast cancer. JAMA Oncol. 2017; 3: 1102 â 1106.; Lindner R, Sullivan C, Offor O, et al. Molecular phenotypes in triple negative breast cancer from African American patients suggest targets for therapy. PLoS One. 2013; 8: e71915.; Yuan J, Hu Z, Mahal BA, et al. Integrated analysis of genetic ancestry and genomic alterations across cancers. Cancer Cell. 2018; 34: 549 â 560.e549.; Ademuyiwa FO, Tao Y, Luo J, Weilbaecher K, Ma CX. Differences in the mutational landscape of tripleâ negative breast cancer in African Americans and Caucasians. Breast Cancer Res Treat. 2017; 161: 491 â 499.; Huang FW, Mosquera JM, Garofalo A, et al. Exome sequencing of Africanâ American prostate cancer reveals lossâ ofâ function ERF mutations. Cancer Discov. 2017; 7: 973 â 983.; Wang H, Schmit SL, Haiman CA, et al. Novel colon cancer susceptibility variants identified from a genomeâ wide association study in African Americans. Int J Cancer. 2017; 140: 2728 â 2733.; Feinberg AP. The key role of epigenetics in human disease prevention and mitigation. N Engl J Med. 2018; 378: 1323 â 1334.; Teschendorff AE, West J, Beck S. Ageâ associated epigenetic drift: implications, and a case of epigenetic thrift? Hum Mol Genet. 2013; 22 ( R1 ): R7 â R15.; Ahmad A, Azim S, Zubair H, et al. Epigenetic basis of cancer health disparities: Looking beyond genetic differences. Biochim Biophys Acta Rev Cancer. 2017; 1868: 16 â 28.